Loading...

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

SFOSFPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$1.96
$0.00(0.00%)

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF) Stock Overview

Explore Shanghai Fosun Pharmaceutical (Group) Co., Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
-0.80%
0.80%
Profit Growth
$1.10
16.08%
EPS Growth
$1.10
16.85%
Operating Margin
10.82%
28.35%
ROE
6.18%
16.08%
Dividend Yield
0.00%
15.56%
Analyst Recommendations data is not available for SFOSFAnalyst Recommendations details for SFOSF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, Other Business segments. The company offers pharmaceutical products in the areas of tumor, immune modulation, metabolism, alimentary and central nervous system. It also provides medical devices and diagnostic products. In addition, the company offers health care and hospital management services. Further, it engages in retail and wholesale distribution of medicines. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.

CEO

Mr. Deyong Wen

Employees

40,557

Headquarters

Building A, Shanghai

Founded

2014

Frequently Asked Questions

;